X0306 4 2020-09-25 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001443898 INTERWEST PARTNERS X LP 467 FIRST STREET, SUITE 201 LOS ALTOS CA 94022 0 0 1 0 0001460207 InterWest Management Partners X, LLC 467 FIRST STREET, SUITE 201 LOS ALTOS CA 94022 0 0 1 0 0001276600 NASR KHALED 467 FIRST STREET, SUITE 201 LOS ALTOS CA 94022 0 0 1 0 0001553019 Desai Keval 467 FIRST STREET, SUITE 201 LOS ALTOS CA 94022 0 0 1 0 0001293171 Kliman Gilbert H 467 FIRST STREET, SUITE 201 LOS ALTOS CA 94022 0 0 1 0 Commonn Stock 2020-09-25 4 P 0 55000 18.00 A 55000 D Common Stock 2020-09-29 4 C 0 1620101 A 1675101 D Common Stock 2020-09-29 4 C 0 3488398 A 5163499 D Common Stock 2020-09-29 4 C 0 1040654 A 6204153 D Common Stock 2020-09-29 4 C 0 265203 A 6469356 D Series Seed Preferred Stock 2020-09-29 4 C 0 1620101 0.00 D Common Stock 1620101 0 D Series A Preferred Stock 2020-09-29 4 C 0 3488398 0.00 D Common Stock 3488398 0 D Series B Preferred Stock 2020-09-29 4 C 0 1040654 0.00 D Common Stock 1040654 0 D Series C Preferred Stock 2020-09-29 4 C 0 265203 0.00 D Common Stock 265203 0 D The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Arnold L. Oronsky, a Managing Director of IMP X, is also a Director of the Issuer and has filed a separate Form 4 in his own name. /s/ Karen Wilson, Attorney-in-Fact for InterWest Partners X, LP 2020-09-29 /s/ Karen Wilson, Attorney-in-Fact for InterWest Management Partners X, LLC 2020-09-29 /s/ Karen Wilson, Attorney-in-Fact for Khaled A. Nasr 2020-09-29 /s/ Karen Wilson, Attorney-in-Fact for Keval Desai 2020-09-29 /s/ Karen Wilson, Attorney-in-Fact for Gilbert H. Kliman 2020-09-29